SGRY Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Surgery Partners Inc (SGRY) is not a strong buy for a beginner, long-term investor at this time. While the stock shows some positive momentum in the short term, the lack of strong proprietary trading signals, insider selling, and mixed technical indicators suggest a cautious approach. The investor may consider holding off until more favorable entry signals or catalysts emerge.
The MACD is positive but contracting, the RSI is neutral at 52.597, and moving averages are converging, indicating no clear trend. Key support and resistance levels are at 14.503 (pivot), 15.268 (R1), and 13.737 (S1). The stock shows a 70% chance of minor gains in the next week but a potential decline in the next month.
Hedge funds are significantly increasing their buying activity, with a 682.35% increase over the last quarter. Analysts maintain a Buy rating and expect gradual improvement in payor mix issues.
Insiders are selling shares, with a 258.25% increase in selling activity over the last month. No recent news or major event-driven catalysts. The stock has a 70% chance of declining by -8.18% in the next month.
No financial data available for analysis.
Jefferies recently raised the price target to $17 from $15, maintaining a Buy rating. Analysts highlight a strong Q1 despite weather-related headwinds and expect gradual improvement in payor mix issues.
